China Universal Asset Management Co., Ltd. Tarsus Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 8,106 shares of TARS stock, worth $419,566. This represents 0.04% of its overall portfolio holdings.
Number of Shares
8,106
Previous 7,317
10.78%
Holding current value
$419,566
Previous $240,000
86.67%
% of portfolio
0.04%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding TARS
# of Institutions
178Shares Held
43.5MCall Options Held
484KPut Options Held
4.1K-
Rtw Investments, LP New York, NY3.41MShares$177 Million1.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$169 Million0.0% of portfolio
-
Jennison Associates LLC2.5MShares$129 Million0.09% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$126 Million2.89% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$117 Million6.32% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.38B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...